Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance.
about
Loss of sugar detection by GLUT2 affects glucose homeostasis in micePhysiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fatObesity associated hypertension: new insights into mechanismThe beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanismsDivergent mechanism regulating fluid intake and metabolism by the brain renin-angiotensin systemModulation of glucose metabolism by the renin-angiotensin-aldosterone systemDirect angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARĪ³ activationMaternal high-fat diet programs rat offspring hypertension and activates the adipose renin-angiotensin systemMouse models of the metabolic syndrome.The renin angiotensin system and the metabolic syndromeReducing plasma membrane sphingomyelin increases insulin sensitivity.The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance.Obesity in kidney disease: A heavyweight opponent.Angiotensin AT(2) receptor contributes towards gender bias in weight gainRenin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in miceAtrial natriuretic peptide and type 2 diabetes development--biomarker and genotype association study.Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice.Early pharmacological inhibition of angiotensin-I converting enzyme activity induces obesity in adulthoodChronic angiotensin AT2R activation prevents high-fat diet-induced adiposity and obesity in female mice independent of estrogen.Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance.Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study.Adipokines and blood pressure controlThe link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertensionDeficiency of angiotensin type 1a receptors in adipocytes reduces differentiation and promotes hypertrophy of adipocytes in lean mice.Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.Transgenic mice overexpressing Renin exhibit glucose intolerance and diet-genotype interactionsThe renin angiotensin aldosterone system and insulin resistance in humans.Metabolic rate regulation by the renin-angiotensin system: brain vs. body.HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders.Fetal programming and cardiovascular pathology.Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus protect against diet-induced obesity.Postprandial fatty acid uptake and adipocyte remodeling in angiotensin type 2 receptor-deficient mice fed a high-fat/high-fructose diet.Fructose: a key factor in the development of metabolic syndrome and hypertension.Angiotensin-converting enzyme inhibition reduces food intake and weight gain and improves glucose tolerance in melanocortin-4 receptor deficient female rats.Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity.Fat utilization and arterial hypertension in overweight/obese subjects.Mitochondrial uncoupling proteins regulate angiotensin-converting enzyme expression: crosstalk between cellular and endocrine metabolic regulators suggested by RNA interference and genetic studiesEffects of angiotensin II type 1 receptor blocker and adiponectin on adipocyte dysfunction in stroke-prone spontaneously hypertensive rats.
P2860
Q21092229-E2ED2B0E-7530-4662-853B-159395C34FB0Q21093205-7B9FACB9-3275-4641-A30C-8F51AED0EDF2Q26827389-CAA8279F-0352-48A3-8C19-9BF19AB08F6FQ27021538-CA674F89-00B7-4595-BF88-E7F4E3345674Q27023126-10B589B3-AFDE-4E0C-B86E-967947A4459AQ27026157-2AC8CD3D-2B7D-4A0B-BB1E-2113AE33FF2FQ28485173-5480251A-98BE-459C-9E4E-F00685DD9DBBQ33567189-A903ECC2-801B-47C2-A33E-359B2AAFD45CQ33849244-FAA8FA1D-A9A3-4DCA-A33F-9857DFA9A6D0Q33915412-842EC4B5-8B52-4409-B263-D0D31EF7BEBEQ34208250-E79B5A58-60C0-439A-96D2-8E3FB14DB2A1Q34362308-928ECA34-F9D1-448C-86C5-5F2A6F23DEA7Q34367664-4A8DAEBC-C913-46ED-AC0A-C1404544CB9BQ34558074-D5293E71-9D64-4ADC-8DE3-6B35AE588761Q34872407-9311E2D9-9528-4BD9-ADB5-C4C2E2BB5C85Q35106848-95BAEC42-E47C-4A46-8E1D-7B64C39DEF4AQ35130413-B608B5F4-7547-4DBB-87C3-7A7C601A4B6BQ35407199-E6D2D4C8-BABE-4324-9F1E-A5447B0D3FB9Q35624869-E4204CFB-B0D9-47FF-A74D-796321D9FF1AQ35736381-5E4CCD0A-83C5-4A00-A634-AE2915F49C46Q35744489-F8E5488A-DAC0-4BEC-A94D-9EEDAFF20DCDQ35889860-71872F13-B8DA-4DFA-862F-4882C743E28AQ35916243-58B4A631-0F41-4840-BFEC-2ECD12BC3356Q36422534-74B32334-774B-42AB-B743-61266C7B1767Q36439462-369580DF-C70A-497E-A247-075D3E9FAE89Q36477252-C99BE97A-282C-4D50-8A7E-DBDCE7D9E9B5Q36512685-BC197828-E1A3-4FB5-9F4F-774938CEC4A4Q36550987-A31A76CB-5C05-44AA-AEF2-33A0F4B11CF7Q36601724-60D41534-7DF7-494F-A366-2AD1ADD111C6Q36603504-2352D0E1-4318-4BAE-85F0-5449831DEEA1Q36635518-4571B8EE-4B3A-4BE5-96B3-6DA2D17A5505Q36736724-7FF8BA38-8B41-4A68-885B-F526126810A9Q36800850-C6A33382-C4A9-40E1-88B7-BD8B5086780AQ36812416-84E224F2-EB4D-4B85-958F-CFA8AA5E1BAAQ36916094-4AAEFC73-02C5-4DB8-935A-8CDBE2FEF8A1Q36927003-78D00C58-C172-48F0-B785-45C3C6FF7F66Q36958256-6BB9A1D7-14C4-46CA-A05B-A253FF65DE2DQ37003955-DDCA27D5-8884-4F40-ADAC-77B3BCC287C6Q37024893-21ED17E6-310B-48EB-B417-F7F90443B84BQ37113912-82D9FBE4-BCBA-49BE-BFFA-36117353D01E
P2860
Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance.
description
2005 nĆ® lÅ«n-bĆ»n
@nan
2005幓ć®č«ę
@ja
2005幓å¦ęÆęē«
@wuu
2005幓å¦ęÆęē«
@zh
2005幓å¦ęÆęē«
@zh-cn
2005幓å¦ęÆęē«
@zh-hans
2005幓å¦ęÆęē«
@zh-my
2005幓å¦ęÆęē«
@zh-sg
2005幓åøč”ęē«
@yue
2005幓åøč”ęē«
@zh-hant
name
Deletion of the angiotensin ty ...... besity and insulin resistance.
@en
Deletion of the angiotensin type 2 receptor
@nl
type
label
Deletion of the angiotensin ty ...... besity and insulin resistance.
@en
Deletion of the angiotensin type 2 receptor
@nl
prefLabel
Deletion of the angiotensin ty ...... besity and insulin resistance.
@en
Deletion of the angiotensin type 2 receptor
@nl
P2093
P50
P1433
P1476
Deletion of the angiotensin ty ...... besity and insulin resistance.
@en
P2093
Annie Quignard-Boulange
May Bloch-Faure
MichĆØle Guerre-Millo
Naima Moustaid-Moussa
P304
P356
10.2337/DIABETES.54.4.991
P407
P577
2005-04-01T00:00:00Z